Cite
HARVARD Citation
Graziani, L. et al. (2023). Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19. Journal of antimicrobial chemotherapy. pp. 555-558. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Graziani, L. et al. (2023). Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19. Journal of antimicrobial chemotherapy. pp. 555-558. [Online].